NCT Number: NCT01626183
Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer
PURPOSE: This laboratory study is looking into RNA in samples from younger patients with T-cell (T) acute lymphoblastic leukemia (ALL).
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- Characterization of the transcriptomic landscape in diagnosis and relapse of T-cell acute lymphoblastic leukemia (ALL) and the direct comparison with corresponding physiological samples (human thymus).
- Perform high-throughput transcriptome ribonucleic acid (RNA) sequencing using matched diagnostic T-precursor pediatric ALL samples (peripheral blood or bone marrow).
OUTLINE: Archived peripheral blood and bone marrow samples are analyzed for long non-coding RNA (IncRNA) expression and sequencing.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Peripheral blood and bone marrow samples from pediatric patients with diagnosed and relapsed T-ALL
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
proteomic profiling
Geneticlaboratory biomarker analysis
OtherPrimary outcomes
-
Identification and characterization of IncRNA of pediatric T-cell acute lymphoblastic leukemia
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Molecular Taxonomy in Pediatric Cancer- IncRNA Expression in Primary T-ALL
Important dates
- Study start
- 2012
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jun 22, 2012
- Registry last updated
- May 17, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
NCT00400946
Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions
Boston, Massachusetts, United States
View Trial DetailsRAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
NCT00081874
Bone Marrow Diseases, Chronic Disease
Houston, Texas, United States
View Trial DetailsBusulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
NCT00534430
Anemia, Anemia, Refractory
View Trial DetailsTocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
NCT03434730
Acute Leukemia, Acute Lymphoblastic Leukemia
New York, United States
View Trial Details